These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
190 related items for PubMed ID: 18835621
1. Comparative analysis of protein expressions in primary and metastatic gastric carcinomas. Kim JH, Kim MA, Lee HS, Kim WH. Hum Pathol; 2009 Mar; 40(3):314-22. PubMed ID: 18835621 [Abstract] [Full Text] [Related]
2. Re-expression of the cadherin-catenin complex in lymph nodes with metastasis in advanced gastric cancer: the relationship with patient survival. Liu J, Ikeguchi M, Nakamura S, Kaibara N. J Exp Clin Cancer Res; 2002 Mar; 21(1):65-71. PubMed ID: 12071532 [Abstract] [Full Text] [Related]
3. Overexpression of GRP78 and GRP94 are markers for aggressive behavior and poor prognosis in gastric carcinomas. Zheng HC, Takahashi H, Li XH, Hara T, Masuda S, Guan YF, Takano Y. Hum Pathol; 2008 Jul; 39(7):1042-9. PubMed ID: 18482745 [Abstract] [Full Text] [Related]
4. Expression of E-cadherin, beta-catenin, CD44s and CD44v6 in gastric adenocarcinoma: relationship with lymph node metastasis. Joo M, Lee HK, Kang YK. Anticancer Res; 2003 Jul; 23(2B):1581-8. PubMed ID: 12820426 [Abstract] [Full Text] [Related]
5. Positive association of up-regulated Cripto-1 and down-regulated E-cadherin with tumour progression and poor prognosis in gastric cancer. Zhong XY, Zhang LH, Jia SQ, Shi T, Niu ZJ, Du H, Zhang GG, Hu Y, Lu AP, Li JY, Ji JF. Histopathology; 2008 Apr; 52(5):560-8. PubMed ID: 18312357 [Abstract] [Full Text] [Related]
6. High expression of PRL-3 can promote growth of gastric cancer and exhibits a poor prognostic impact on patients. Wang Z, Cai SR, He YL, Zhan WH, Chen CQ, Cui J, Wu WH, Wu H, Song W, Zhang CH, Peng JJ, Huang XH. Ann Surg Oncol; 2009 Jan; 16(1):208-19. PubMed ID: 19009246 [Abstract] [Full Text] [Related]
7. Paradoxical expression of maspin in gastric carcinomas: correlation with carcinogenesis and progression. Yu M, Zheng H, Tsuneyama K, Takahashi H, Nomoto K, Xu H, Takano Y. Hum Pathol; 2007 Aug; 38(8):1248-55. PubMed ID: 17490717 [Abstract] [Full Text] [Related]
8. High epidermal growth factor receptor expression in metastatic colorectal cancer lymph nodes may be more prognostic of poor survival than in primary tumor. Deng Y, Kurland BF, Wang J, Bi J, Li W, Rao S, Lan P, Lin T, Lin E. Am J Clin Oncol; 2009 Jun; 32(3):245-52. PubMed ID: 19451802 [Abstract] [Full Text] [Related]
9. Increased expression of galectin-3 in primary gastric cancer and the metastatic lymph nodes. Miyazaki J, Hokari R, Kato S, Tsuzuki Y, Kawaguchi A, Nagao S, Itoh K, Miura S. Oncol Rep; 2002 Jun; 9(6):1307-12. PubMed ID: 12375039 [Abstract] [Full Text] [Related]
10. Expression levels of cyclin G2, but not cyclin E, correlate with gastric cancer progression. Choi MG, Noh JH, An JY, Hong SK, Park SB, Baik YH, Kim KM, Sohn TS, Kim S. J Surg Res; 2009 Dec; 157(2):168-74. PubMed ID: 19559447 [Abstract] [Full Text] [Related]
11. Loss of KAI1 expression in gastric cancer. Tsutsumi S, Shimura T, Morinaga N, Mochiki E, Asao T, Kuwano H. Hepatogastroenterology; 2005 Dec; 52(61):281-4. PubMed ID: 15783050 [Abstract] [Full Text] [Related]
12. Expression of multidrug-resistance-related proteins P-glycoprotein, glutathione-S-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma. Shi H, Lu D, Shu Y, Shi W, Lu S, Wang K. Cancer Invest; 2008 May; 26(4):344-51. PubMed ID: 18443954 [Abstract] [Full Text] [Related]
13. Postoperative autovaccinotherapy for patients with gastric cancer and expression of some proteins in tumor tissue. Bazas VM, Lukyanova NY, Lisovenko GS, Rozumiy DO, Potebnya GP. Exp Oncol; 2009 Sep; 31(3):182-4. PubMed ID: 19783961 [Abstract] [Full Text] [Related]
14. [Expression and significance of MRP, GST-pi, Topo IIalpha, and LRP in gastric carcinoma]. Yu DQ, Yi YF. Ai Zheng; 2003 May; 22(5):496-9. PubMed ID: 12753710 [Abstract] [Full Text] [Related]
15. Decreased expression of RASSF6 is a novel independent prognostic marker of a worse outcome in gastric cancer patients after curative surgery. Wen Y, Wang Q, Zhou C, Yan D, Qiu G, Yang C, Tang H, Peng Z. Ann Surg Oncol; 2011 Dec; 18(13):3858-67. PubMed ID: 21442347 [Abstract] [Full Text] [Related]
16. Immunohistochemical study of E-cadherin and β-catenin expression in colorectal carcinomas. Ozgüven BY, Karaçetin D, Kabukçuoğlu F, Taşkin T, Yener Ş. Pol J Pathol; 2011 Dec; 62(1):19-24. PubMed ID: 21574102 [Abstract] [Full Text] [Related]
17. Approaching heterogeneity of human epidermal growth factor receptor 2 in surgical specimens of gastric cancer. Asioli S, Maletta F, Verdun di Cantogno L, Satolli MA, Schena M, Pecchioni C, Botta C, Chiusa L, Molinaro L, Conti L, Viale G, Ingravallo G, Maiorano E, Sapino A. Hum Pathol; 2012 Nov; 43(11):2070-9. PubMed ID: 22658277 [Abstract] [Full Text] [Related]
18. The significances of lymph node micrometastasis and its correlation with E-cadherin expression in pT1-T3N0 gastric adenocarcinoma. Kim JH, Park JM, Jung CW, Park SS, Kim SJ, Mok YJ, Kim CS, Chae YS, Bae JW. J Surg Oncol; 2008 Feb 01; 97(2):125-30. PubMed ID: 18095267 [Abstract] [Full Text] [Related]
19. Gastric neuroendocrine carcinoma: clinicopathologic review and immunohistochemical study of E-cadherin and Ki-67 as prognostic markers. Boo YJ, Park SS, Kim JH, Mok YJ, Kim SJ, Kim CS. J Surg Oncol; 2007 Feb 01; 95(2):110-7. PubMed ID: 17066436 [Abstract] [Full Text] [Related]
20. Value of glutathione S-transferase pi and the oncogene products c-Jun, c-Fos, c-H-Ras, and c-Myc as a prognostic indicator in endometrial carcinomas. Yokoyama Y, Sagara M, Sato S, Saito Y. Gynecol Oncol; 1998 Mar 01; 68(3):280-7. PubMed ID: 9570981 [Abstract] [Full Text] [Related] Page: [Next] [New Search]